Antileishmanial activities of stearylamine-bearing liposomes

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1739-1742

  Dey, Tuhina ^a   Anam, Khairul ^a   Afrin, Farhat ^a   Ali, Nahid ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG EFFICACY; FEMALE; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; VISCERAL LEISHMANIASIS;

AMINES; ANIMALS; DERMATOLOGIC AGENTS; DRUG CARRIERS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; MICE; MICE, INBRED BALB C;

EID: 0034077978     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1739-1742.2000     Document Type: Article

References (23)

1. Afrin, F., and N. Ali. 1997. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect. Immun. 65:2371-2377.
2. Alving, C. R. 1983. Delivery of liposome-encapsulated drugs to macrophages. Pharmacol. Ther. 22:407-424.
3. Berman, J. D. 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:684-703.
4. Black, C. D. V., G. J. Watson, and R. J. Ward. 1977. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 71:550-552.
5. Bryceson, A. D. M. 1987. Therapy in man, p. 848-907. In P. W. Killick and R. Kendrick (ed.), Leishmaniasis in biology and medicine. Academic Press Ltd., London, England.
6. Davidson, R. N., S. L. Croft, A. Scott, M. Miani, A. H. Moody, and A. D. M. Bryceson. 1991. Liposomal amphotericin B in drug resistant visceral leishmaniasis. Lancet 337:1061-1062.
7. Dwyer, D. M. 1977. Leishmania donovani: surface membrane carbohydrates of promastigotes. Exp. Parasitol. 41:341-358.
8. Filion, M. C., and N. C. Philips. 1997. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1329:345-356.
9. Herwaldt, B. L., and J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46:296-306.
10. Huang, L., and S. Li. 1997. Liposomal gene delivery: a complex package. Nat. Biotechnol. 15:620-621.
11. King, D. L., Y. D. Chang, and S. J. Turco. 1987. Cell surface lipophosphoglycan of Leishmania donovani. Mol. Biochem. Parasitol. 24:47-53.
12. Liu, F., and D. Liu. 1996. Serum independent liposome uptake by mouse liver. Biochim. Biophys. Acta 1278:5-11.
13. Miller, C. R., B. Bondurant, S. D. McLean, K. A. McGovern, and D. F. O'Brien. 1998. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 37:12875-12883.
14. Nakanishi, T., J. Kunisawa, A. Hayashi, Y. Tsutsumi, K. Kubo, S. Nakagawa, H. Fujiwara, T. Hamaoka, and T. Mayumi. 1997. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun. 240:793-797.
15. New, R. R. C., M. L. Chance, S. C. Thomas, and W. Peters. 1978. Antileishmanial activity of antimonials trapped in liposomes. Nature 272:55-56.
16. Pimenta, P. F. P., and W. de Souza. 1983. Leishmania mexicana amazonensis: surface charge of amastigote and promastigote forms. Exp. Parasitol. 56: 194-206.
17. Sundar, S., F. Rosenkaimer, and H. W. Murray. 1994. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. J. Infect. Dis. 170:659-662.
18. Tachibana, H., E. Yoshihara, Y. Kaneda, and T. Nakae. 1988. In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylaminebearing liposomes. Antimicrob. Agents Chemother. 32:966-970.
19. Tachibana, H., E. Yoshihara, Y. Kaneda, and T. Nakae. 1990. Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes. J. Parasitol. 76:352-355.
20. Torre-Cisneros, J., J. L. Villanueva, J. M. Kindelan, R. Jurado, and P. Sanchez-Guijo. 1993. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 17:625-627.
21. Vidal, M., and D. Hoekstra. 1995. In vitro fusion of reticulocyte endocytic vesicles with liposomes. J. Biol. Chem. 270:17823-17829.
22. Woodle, M. C., and D. D. Lasic. 1992. Sterically stabilized liposomes. Biochim. Biophys. Acta 1113:171-199.
23. Yoshihara, E., H. Tachibana, and T. Nakae. 1987. Trypanocidal activity of stearylamine-bearing liposomes in vitro. Life Sci. 40:2153-2159.